Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Nitric Oxide and Riboflavin

supplement:

Riboflavin

Research Papers that Mention the Interaction

A possible role of riboflavin in the modulation of toxic and signal pathways of nitrogen oxide is discussed.
Biofizika  •  2002  |  View Paper
Recently, we have reported that NO production was inhibited by naturally-occurring proteasome inhibitors (quercetin, δ-tocotrienol, and riboflavin ) in lipopolysaccharide (LPS)-stimulated RAW264.7 cells, and thioglycolate-elicited peritoneal macrophages from C57BL/6 mice.
Lipids in Health and Disease  •  2012  |  View Paper
ConclusionsResults of the current study demonstrate that δ-tocotrienol, riboflavin , and quercetin inhibit NO production by LPS-stimulated macrophages of all four strains of mice, and TNF-α secretion only by LPS-stimulated macrophages of C57BL/6 and BALB/c mice.
Lipids in Health and Disease  •  2011  |  View Paper
Vitamin B2 … NO levels in accordance with a reduction in expression of inducible NO synthase (iNOS) both at 21 and 24 h. Accordingly, the reduction in … based on the inhibitory effect on local cytokine mRNA expression and iNOS would be responsible for the anti-septic effect of vitamin B2.
Life sciences  •  2005  |  View Paper
Riboflavin treatment also decreased NO and TNF-α level possibly by inhibiting the NF-κβ pathway.
Journal of Inflammation  •  2016  |  View Paper
Nutrients such as arginine, antioxidants (vitamins C and E, lipoic acid, glutathione), and enzyme cofactors vitamins B2 and B3, folate, and tetrahydrobiopterin) help to elevate nitric oxide levels and may play an important role in the management of cardiovascular disease.
Alternative medicine review : a journal of clinical therapeutic  •  2004  |  View Paper